作為EGFR抑制劑的新的嘧啶和治療病症的方法
- 专利权人:
- DANA-FARBER CANCER INSTITUTE; INC.
- 发明人:
- GRAY, Nathanael, S.,JANNE, Pasi,CHOI, Hwan, Geun,JANG, Jaebong
- 申请号：
- HK18105758.1
- 公开号：
- HK1246231A
- 申请日:
- 2018.05.04
- 申请国别(地区):
- HK
- 年份:
- 2018
- 代理人:
- 摘要：
- which modulates the activity of EGFR, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease in which EGFR plays a role.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS
- Novel pyrimidines as EGFR inhibitors and methods of treating disorders
- NOUVELLES PYRIMIDINES UTILES EN TANT QU'INHIBITEURS D'EGFR ET MÉTHODES DE TRAITEMENT DE TROUBLES
- Inhibitors of EGFR and methods of use thereof
- Inhibitors of EGFR and/or HER2 and methods of use
